BIOPHARM WINS EXCELLENCE IN GENERIC MEDICINE DEVELOPMENT IN ALGERIA AT THE GLOBAL BRAND AWARDS 2024
Biopharm, a leading pharmaceutical company in Algeria, has been awarded the prestigious title of 'Excellence in Generic ...
The Manila Times1d
ARTMS Drug Master File for Gallium Production Technology Referenced with Telix's Gozellix®
(ARTMS), a global leader in radioisotope production technologies, is pleased to announce that the drug master file (DMF) 1 ...
Houston-area company may be developing next hot weight-loss drug
Lexicon Pharmaceuticals, headquartered in The Woodlands, announced it will exclusively license its drug LX9851 to the maker ...
TMCnet1d
Innocan Pharma Reports Full Year 2024 Results with Revenues more than Doubling to US $29.4 million
Gross Profit increased 118.6% year-over-year to US$26.2 million for the year ended December 31, 2024, compared to US$12.0 ...
Ascendis Submits U.S. NDA for TransCon CNP (Navepegritide) for the Treatment of Children with Achondroplasia
Data demonstrated multiple clinical benefits beyond linear growth— NDA supported by data from three randomized, double-blind, ...
Knight Therapeutics Announces Launch of Minjuvi® (tafasitamab) in Mexico
MONTREAL, March 26, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a pan-American (ex-US) specialty pharmaceutical company, announced today the launch of Minjuvi ® ...
The Gazette12d
Gene therapy loses luster as investors eye quicker returns from weight-loss drugs
Vertex Pharmaceuticals continues to see patients with sickle cell ... He said the treatment, which had 2024 sales of just $10 ...
조선일보18d
ENCell, CMIC Group sign MOUs for collaboration in cell therapy and pet products
a subsidiary of the major Japanese pharmaceutical distribution company, Alpresa Group. Following the MOU, both parties will discuss contracts for transferring ENCell's CDMO technology and ...